AGN-190584 + Vehicle
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Presbyopia
Conditions
Presbyopia
Trial Timeline
May 14, 2021 → Dec 7, 2021
NCT ID
NCT04837482About AGN-190584 + Vehicle
AGN-190584 + Vehicle is a phase 3 stage product being developed by AbbVie for Presbyopia. The current trial status is completed. This product is registered under clinical trial identifier NCT04837482. Target conditions include Presbyopia.
What happened to similar drugs?
1 of 5 similar drugs in Presbyopia were approved
Approved (1) Terminated (1) Active (4)
🔄Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + Placebo (Vehicle) ophthalmic solutionLENZ TherapeuticsPhase 3
🔄Aceclidine+Brimonidine combination ophthalmic solution + Placebo + Aceclidine Ophthalmic SolutionLENZ TherapeuticsPhase 3
🔄Aceclidine+Brimonidine combination ophthalmic solution + Aceclidine ophthalmic solution + VehicleLENZ TherapeuticsPhase 3
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04837482 | Phase 3 | Completed |
Competing Products
14 competing products in Presbyopia